Jorma Strand
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 3
- Diabetes Management and Research 2
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
-
- Metabolism, Diabetes, and Cancer 2
- Co-authors
- Michel Marre (1 shared paper)Michael Brändle (1 shared paper)Marija Zdravković (1 shared paper)Stephen Colagiuri (1 shared paper)Nor Azmi Kamaruddin (1 shared paper)Meng H. Tan (2 shared papers)Vinod Mattoo (1 shared paper)Santiago Durán (1 shared paper)
- Journals
- Diabetic Medicine (2 papers)Clinical Therapeutics (1 paper)Atherosclerosis Supplements (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- FinlandUnited StatesDenmark
In The Last Decade
Jorma Strand
5 papers receiving 784 citations
Jorma Strand's Hit Papers
Peers
Comparison fields: 5 of 54
- Endocrinology, Diabetes and Metabolism 759
- Pharmacology 196
- Molecular Biology 456
- Surgery 281
- Family Practice 8
Countries citing papers authored by Jorma Strand
This map shows the geographic impact of Jorma Strand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorma Strand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorma Strand more than expected).
Fields of papers citing papers by Jorma Strand
This network shows the impact of papers produced by Jorma Strand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorma Strand. The network helps show where Jorma Strand may publish in the future.
Co-authors
The 25 scholars most cited alongside Jorma Strand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU) Hit paper breakdown → | 2009 | 687 |
| 2 | 2005 | 79 | |
| 3 | 2004 | 58 | |
| 4 | 2020 | 11 | |
| 5 | 2006 | 1 |
About Jorma Strand
Jorma Strand is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Nephrology and Genetics, having authored 5 papers that have together received 836 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Diabetes Management and Research (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Mast cells and histamine (1 paper), Renal Diseases and Glomerulopathies (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (759 citations), Pharmacology (196 citations), Molecular Biology (456 citations), Surgery (281 citations) and Family Practice (8 citations). Jorma Strand has collaborated with scholars based in Finland, United States and Denmark. Frequent co-authors include Michel Marre, Michael Brändle, Marija Zdravković, Stephen Colagiuri, Nor Azmi Kamaruddin, Meng H. Tan, Vinod Mattoo, Santiago Durán, Mario Widel and D Oakley. Their work appears in journals such as Diabetic Medicine, Clinical Therapeutics, Atherosclerosis Supplements and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.